Regulation of Bcl xL expression in lung vascular smooth muscle

American Journal of Respiratory Cell and Molecular Biology

Volumn 36, Issue 6, 2007, Pages 678-687

  Suzuki, Yuichiro J ^a   Nagase, Hiroko ^b   Chi, Ming Wong ^b   Kumar, Shilpashree Vinod ^b   Jain, Vivek ^b   Park, Ah Mee ^b   Day, Regina M ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Apoptosis; Genes; Pulmonary hypertension; Smooth muscle

Indexed keywords

ADENOVIRUS VECTOR; INHIBITOR OF APOPTOSIS PROTEIN 1; NITROPRUSSIDE SODIUM; PROTEIN BCL XL; TRANSCRIPTION FACTOR GATA 4; ENDOTHELIN 1; NITRIC OXIDE DONOR; PROTEIN BCL X; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BCL XL GENE; CONTROLLED STUDY; GATA4 GENE; GENE; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HYPOXIA; LUNG ARTERY; MALE; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CATTLE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; HUMAN; LUNG; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; RATTUS;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CATTLE; ENDOTHELIN-1; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; LUNG; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE DONORS; NITROPRUSSIDE; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 34249905501     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2006-0359OC     Document Type: Article

References (43)

1. Nishimura T, Vaszar LT, Faul JL, Zhao G, Berry GJ, Shi L, Qiu D, Benson G, Pearl RG, Kao PN. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 2003;108:1640-1645.
2. K(V) and enhances apoptosis. Am J Physiol 2004;287: C715-C722.
3. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, Hashimoto K, Michelakis ED. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 2004;95:830-840.
4. McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, Bonnet S, Puttagunta L, Michelakis ED. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005;115:1479-1491.
5. Merklinger SL, Jones PL, Martinez EC, Rabinovitch M. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation 2005;112:423-431.
6. Sorenson CM. Bcl-2 family members and disease. Biochim Biophys Acta 2004;1644:169-177.
7. L. J Biol Chem 1996;271:6306-6312.
8. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
9. S sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 1995;55:2507-2510.
10. S adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells. Neoplasia 2000;2:251-260.
11. S gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res 1996;56:1965-1969.
12. S enhances adenoviral vector-induced apoptosis in neuroblastoma cells. Cancer Res 1996;56: 5734-5740.
13. S adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci USA 1995;92:11024-11028.
14. Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 1998;4:222-227.
15. Suzuki J, Isobe M, Morishita R, Nishikawa T, Amano J, Kaneda Y. Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts. Cardiovasc Res 2000;45:783-787.
16. Suzuki J, Iwai M, Nakagami H, Wu L, Chen R, Sugaya T, Hamada M, Hiwada K, Horiuchi M. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 2002;106:847-853.
17. Jankov RP, Kantores C, Belcastro R, Yi M, Tanswell AK. Endothelin-1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal rat. Pediatr Res 2006;60:245-251.
18. He CH, Waxman AB, Lee CG, Link H, Rabach ME, Ma B, Chen Q, Zhu Z, Zhong M, Nakayama K, et al. Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest 2005;115:1039-1048.
19. Lee SL, Wang WW, Fanburg BL. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res 1991; 68:1362-1368.
20. Kitta K, Day RM, Ikeda T, Suzuki YJ. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med 2001;31:902-910.
21. Suzuki YJ, Day RM, Tan CC, Sandven TH, Liang Q, Molkentin JD, Fanburg BL. Activation of GATA-4 by serotonin in pulmonary artery smooth muscle cells. J Biol Chem 2003;278:17525-17531.
22. Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF, Nunez G. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol 1997;158:4750-4757.
23. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;198:1141-1150.
24. B receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002;165:398-405.
25. Pecci A, Viegas LR, Baranao JL, Beato M. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. J Biol Chem 2001;276:21062-21069.
26. Smith JD, McLean SD, Nakayama DK. Nitric oxide causes apoptosis in pulmonary vascular smooth muscle cells. J Surg Res 1998;79:121-127.
27. + channels in pulmonary vascular smooth muscle cells. Am J Physiol 2002;282: H184-H193.
28. Wedgwood S, Black SM. Molecular mechanisms of nitric oxide-induced growth arrest and apoptosis in fetal pulmonary arterial smooth muscle cells. Nitric Oxide 2003;9:201-210.
29. Roberts JD, Polaner DM, Lan P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-819.
30. Snell GI, Salamonsen RF, Bergin P, Esmore DS, Khan S, Williams TJ. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1263-1266.
31. Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR. Fedullo PF, Moser KM. Pulse delivery of inhaled nitric oxide to patients with primary pulmonary hypertension. Chest 1996;109:1545-1549.
32. Perez-Penate G, Julia-Serda G, Pulido-Duque JM, Gorriz-Gomez E, Cabrera-Navarro P. One-year continuous inhaled nitric oxide for primary pulmonary hypertension. Chest 2001;119:970-973.
33. Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci USA 2004;101:6975-6980.
34. Cowan KN, Jones PL, Rabinovitch M. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 1999;84:1223-1233.
35. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res 1996;79:748-756.
36. Hampl V, Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 2000;80:1337-1372.
37. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001;163:737-744.
38. Geraci MW, Moore M, Gesell T, Yeager ME, Alger L, Golpon H. Gao B, Loyd JE, Tuder RM, Voelkel NF. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 2001;88:555-562.
39. Riley DJ, Thakker-Varia S, Wilson FJ, Poiani GJ, Tozzi CA. Role of proteolysis and apoptosis in regression of pulmonary vascular remodeling. Physiol Res 2000;49:577-585.
40. L expression. Blood 1999;94:87-96.
41. Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y, Simon AR, Evans T, Suzuki YJ. Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 2003;63:368-377.
42. Kitta K, Day RM, Kim Y, Torregroza I, Evans T, Suzuki YJ. Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 2003;278:4705-4712.
43. Lawrie A, Spickerkoetter E, Martinez EC, Ambartsumian N, Sheward WJ, MacLean MR, Harmar AJ, Schmidt AM, Lukanidin E, Rabinovitch M. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 2005;97:227-235.